Rani Therapeutics has appointed Jesper Høiland as the Head of Strategy, effective March 25, 2026. Høiland, who has been a strategic adviser since 2023, brings over 30 years of experience in the pharmaceutical sector, particularly in obesity and metabolic diseases. He will focus on shaping Rani’s corporate strategies, evaluating new therapeutic opportunities, and enhancing partnership development, leveraging his extensive background, including leadership roles at Ascendis Pharma and Novo Nordisk. Høiland expressed enthusiasm about Rani’s potential to transform oral biologic delivery.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.manilatimes.net/2026/03/26/tmt-newswire/globenewswire/rani-therapeutics-appoints-jesper-hiland-as-head-of-strategy-to-advance-corporate-and-pipeline-prioritization/2307961
